Published in Infect Control Hosp Epidemiol on April 19, 2013
Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections. World J Gastroenterol (2016) 0.86
Fecal microbiota transplantation for the treatment of Clostridium difficile infection. J Hosp Med (2015) 0.85
WSES guidelines for management of Clostridium difficile infection in surgical patients. World J Emerg Surg (2015) 0.85
Intestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection. Dig Dis Sci (2014) 0.84
Editorial commentary: Host-pathogen interactions in Clostridium difficile infection: it takes two to tango. Clin Infect Dis (2014) 0.81
Economics and financing of vaccines for diarrheal diseases. Hum Vaccin Immunother (2014) 0.77
Host response to Clostridium difficile infection: Diagnostics and detection. J Glob Antimicrob Resist (2016) 0.75
Financial impact of health care-associated infections: When money talks. Can J Infect Dis Med Microbiol (2014) 0.75
Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect Dis (2016) 0.75
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol (2010) 17.99
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet (2005) 12.54
Burden of Clostridium difficile infection in the United States. N Engl J Med (2015) 8.17
Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis (2005) 4.52
Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis (2008) 3.95
Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis (2011) 3.78
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol (2003) 3.46
Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis (2007) 3.21
Current status of Clostridium difficile infection epidemiology. Clin Infect Dis (2012) 3.14
An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus. Clin Infect Dis (2006) 2.98
Stage-based expert systems to guide a population of primary care patients to quit smoking, eat healthier, prevent skin cancer, and receive regular mammograms. Prev Med (2005) 2.95
Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis (2006) 2.79
Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med (2013) 2.78
Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis (2008) 2.61
Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis (2006) 2.43
A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc (2011) 2.37
The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis (2012) 2.34
ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis (2006) 2.27
Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis (2009) 2.24
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan. Antimicrob Agents Chemother (2007) 2.01
Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol (2009) 2.00
Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis (2008) 1.98
Burden of early-onset candidemia: analysis of culture-positive bloodstream infections from a large U.S. database. Crit Care Med (2009) 1.93
Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med (2006) 1.91
Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect (2010) 1.83
Using automated clinical data for risk adjustment: development and validation of six disease-specific mortality predictive models for pay-for-performance. Med Care (2007) 1.75
National estimates of central line-associated bloodstream infections in critical care patients. Infect Control Hosp Epidemiol (2013) 1.69
Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis (2008) 1.67
The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis (2007) 1.66
Multiple risk expert systems interventions: impact of simultaneous stage-matched expert system interventions for smoking, high-fat diet, and sun exposure in a population of parents. Health Psychol (2004) 1.65
Pancreatic stent placement for duct disruption. Gastrointest Endosc (2002) 1.62
Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock. Crit Care Med (2014) 1.61
Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitals. Clin Infect Dis (2013) 1.60
Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol (2009) 1.58
Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med (2008) 1.58
A national survey of severe influenza-associated complications among children and adults, 2003-2004. Clin Infect Dis (2005) 1.56
Vancomycin-resistant staphylococci and enterococci: epidemiology and control. Curr Opin Infect Dis (2005) 1.56
Possible seasonality of Clostridium difficile in retail meat, Canada. Emerg Infect Dis (2009) 1.55
Demographic variables, smoking variables, and outcome across five studies. Health Psychol (2007) 1.55
Should Do-Not-Resuscitate status be included as a mortality risk adjustor? The impact of DNR variations on performance reporting. Med Care (2005) 1.54
Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis (2010) 1.53
Increased mortality and length of stay among patients with inflammatory bowel disease and hospital-acquired infections. Clin Gastroenterol Hepatol (2010) 1.51
Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. Arch Intern Med (2007) 1.50
Wrestling SARS from uncertainty. Emerg Infect Dis (2004) 1.50
Growth in dementia-associated hospitalizations among the oldest old in the United States: implications for ethical health services planning. Arch Intern Med (2011) 1.46
Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. Infect Control Hosp Epidemiol (2008) 1.45
Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis (2004) 1.45
Clostridium difficile-related hospitalizations among US adults, 2006. Emerg Infect Dis (2009) 1.39
Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect Control Hosp Epidemiol (2009) 1.38
A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors. Am J Med (2011) 1.38
Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control (2007) 1.35
A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med (2006) 1.34
Vancomycin-resistant enterococci from humans and retail chickens in Taiwan with unique VanB phenotype-vanA genotype incongruence. Antimicrob Agents Chemother (2002) 1.31
The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004. Diagn Microbiol Infect Dis (2008) 1.31
Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes. Infect Control Hosp Epidemiol (2010) 1.29
Infection control in the multidrug-resistant era: tending the human microbiome. Clin Infect Dis (2011) 1.26
Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol (2008) 1.25
Hospital resource utilization and costs of inappropriate treatment of candidemia. Pharmacotherapy (2010) 1.25
Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect Control Hosp Epidemiol (2009) 1.23
Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion. Obstet Gynecol (2007) 1.23
A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am J Gastroenterol (2009) 1.22
Development and validation of a disease-specific risk adjustment system using automated clinical data. Health Serv Res (2010) 1.21
A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy. Clin Infect Dis (2007) 1.20
Developing and validating a risk score for lower-extremity amputation in patients hospitalized for a diabetic foot infection. Diabetes Care (2011) 1.18
Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol (2008) 1.18
Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species. J Clin Microbiol (2005) 1.15
Using electronic health record data to develop inpatient mortality predictive model: Acute Laboratory Risk of Mortality Score (ALaRMS). J Am Med Inform Assoc (2013) 1.13
Clostridium difficile: responding to a new threat from an old enemy. Infect Control Hosp Epidemiol (2005) 1.10
Early changes in blood urea nitrogen predict mortality in acute pancreatitis. Gastroenterology (2009) 1.10
Bench-to-bedside review: Clostridium difficile colitis. Crit Care (2008) 1.08
Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. Infect Control Hosp Epidemiol (2007) 1.08
Burden of Clostridium difficile infection in the United States. N Engl J Med (2015) 1.07
Alcohol-use disorders in the critically ill patient. Chest (2010) 1.07
Clostridium difficile infections in children. Pediatr Infect Dis J (2009) 1.07
Assessment of reporting bias for Clostridium difficile hospitalizations, United States. Emerg Infect Dis (2008) 1.05
Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals. Infect Control Hosp Epidemiol (2011) 1.05
Lack of SARS transmission among healthcare workers, United States. Emerg Infect Dis (2004) 1.04
Development and validation of a mortality risk-adjustment model for patients hospitalized for exacerbations of chronic obstructive pulmonary disease. Med Care (2013) 1.03
Clostridium difficile strains from community-associated infections. J Clin Microbiol (2009) 1.03
Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis (2013) 1.03
Hospitalization for community-acquired pneumonia: the pneumonia severity index vs clinical judgment. Chest (2003) 1.02
Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada. PLoS One (2010) 1.01
Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med (2009) 1.01
Clostridium difficile infection among children across diverse US geographic locations. Pediatrics (2014) 1.01
Undiagnosed cases of fatal Clostridium-associated toxic shock in Californian women of childbearing age. Am J Obstet Gynecol (2009) 1.00
Evaluation of organizational culture among different levels of healthcare staff participating in the Institute for Healthcare Improvement's 100,000 Lives Campaign. Infect Control Hosp Epidemiol (2011) 1.00
Physician reminders to promote surveillance colonoscopy for colorectal adenomas: a randomized controlled trial. J Gen Intern Med (2008) 0.99
Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia. Infect Control Hosp Epidemiol (2009) 0.99